Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline

Journal of Nuclear Medicine

Volumn 52, Issue 1, 2011, Pages 107-114

  Buck, Jason R ^a,b   McKinley, Eliot T ^a,c   Hight, Matthew R ^a,c   Fu, Allie ^a   Tang, Dewei ^a,d   Smith, Ralph Adam ^a,b   Tantawy, Mohammed Noor ^a,b   Peterson, Todd E ^a,b,d   Colvin, Daniel ^a,b   Ansari, Mohammed Sib ^a,b   Baldwin, Ronald M ^a,b   Zhao, Ping ^a   Guleryuz, Saffet ^a   Manning, H Charles ^a,b,c,d,e  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Cancer; PBR; PBR06; Positron emission tomography PET; TSPO

Indexed keywords

CARRIER PROTEIN; FLUORINE 18; N FLUOROACETYL N (2,5 DIMETHOXYBENZYL) 2 PHENOXYANILINE F 18; RADIOLIGAND; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL BLOOD; ARTICLE; BINDING AFFINITY; CANCER TISSUE; COMPARTMENT MODEL; CONTROLLED STUDY; CORRELATION ANALYSIS; EX VIVO STUDY; GLIOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGING; IMMUNOHISTOCHEMISTRY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; TUMOR CELL; WESTERN BLOTTING;

ACETANILIDES; ANIMALS; CARRIER PROTEINS; CELL LINE, TUMOR; FLUORINE RADIOISOTOPES; GLIOMA; ISOQUINOLINES; MALE; MODELS, BIOLOGICAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; RECEPTORS, GABA-A;

EID: 79851499878     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.081703     Document Type: Article

References (28)

1. Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006;27:402-409. (Pubitemid 44069585)
2. Batarseh A, Papadopoulos V. Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol Cell Endocrinol. 2010;327:1-12.
3. Maaser K, Grabowski P, Sutter AP, et al. Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer. Clin Cancer Res. 2002;8:3205-3209. (Pubitemid 35155032)
4. 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med. 2004;45:1293-1298.
5. Cornu P, Benavides J, Scatton B, Hauw JJ, Philippon J. Increase in omega 3 (peripheral-type benzodiazepine) binding site densities in different types of human brain tumours: a quantitative autoradiography study. Acta Neurochir (Wien). 1992;119:146-152. (Pubitemid 23022785)
6. Black KL, Ikezaki K, Toga AW. Imaging of brain-tumors using peripheral benzodiazepine receptor ligands. J Neurosurg. 1989;71:113-118. (Pubitemid 19196561)
7. Junck L, Olson JM, Ciliax BJ, et al. PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann Neurol. 1989;26:752-758. (Pubitemid 20011009)
8. Olson JM, Junck L, Young AB, Penney JB, Mancini WR. Isoquinoline and peripheral-type benzodiazepine binding in gliomas: implications for diagnostic imaging. Cancer Res. 1988;48:5837-5841.
9. Pappata S, Cornu P, Samson Y, et al. PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. J Nucl Med. 1991;32:1608-1610.
10. Starosta-Rubinstein S, Ciliax BJ, Penney JB, McKeever P, Young AB. Imaging of a glioma using peripheral benzodiazepine receptor ligands. Proc Natl Acad Sci USA. 1987;84:891-895. (Pubitemid 17033913)
11. 11C]PK11195 challengers. Eur J Nucl Med Mol Imaging. 2008;35:2304-2319.
12. 11C]DAA1106. Biol Psychiatry. 2008;64:835-841.
13. 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain. J Nucl Med. 2006;47:43-50.
14. 18F-PBR06. J Nucl Med. 2009;50:1047-1053.
15. 18F-labeled ligand for imaging brain peripheral benzodiazepine receptors with PET. J Med Chem. 2009;52:688-699.
16. Kozikowski AP, Kotoula M, Ma D, Boujrad N, Tuckmantel W, Papadopoulos V. Synthesis and biology of a 7-nitro-2,1,3-benzoxadiazol-4-yl derivative of 2-phenylindole-3-acetamide: a fluorescent probe for the peripheral-type benzodiazepine receptor. J Med Chem. 1997;40:2435-2439.
17. Cleveland WS, Devlin SJ. Locally weighted regression: an approach to regression-analysis by local fitting. J Am Stat Assoc. 1988;83:596-610.
18. Muzic RF Jr, Cornelius S. COMKAT: compartment model kinetic analysis tool. J Nucl Med. 2001;42:636-645. (Pubitemid 32298286)
19. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834-840. (Pubitemid 26292051)
20. Imaizumi M, Briard E, Zoghbi SS, et al. Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain. Synapse. 2007;61:595-605. (Pubitemid 46934006)
21. Hardwick M, Fertikh D, Culty M, Li H, Vidic B, Papadopoulos V. Peripheraltype benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res. 1999;59:831-842. (Pubitemid 29086736)
22. Batarseh A, Li J, Papadopoulos V. Protein kinase C epsilon regulation of translocator protein (18 kDa) Tspo gene expression is mediated through a MAPK pathway targeting STAT3 and c-Jun transcription factors. Biochemistry. 2010;49:4766-4778.
23. 3H] DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors. Eur J Pharmacol. 1999;371:197-204.
24. Nagler R, Ben-Izhak O, Savulescu D, et al. Oral cancer, cigarette smoke and mitochondrial 18 kDa translocator protein (TSPO): in vitro, in vivo, salivary analysis. Biochim Biophys Acta. 2010;1802:454-461.
25. Nagler R, Savulescu D, Krayzler E, Leschiner S, Veenman L, Gavish M. Cigarette smoke decreases salivary 18 kDa translocator protein binding affinity: in association with oxidative stress. Curr Med Chem. 2010;17:2539-2546.
26. -/- mice discriminates cancer and inflammation. Mol Cancer Res. 2007;5:341-349.
27. Tang D, Buck JR, Hight MR, Manning HC. Microwave-assisted organic synthesis of a high-affinity pyrazolo-pyrimidinyl TSPO ligand. Tetrahedron Lett. 2010;51:4595-4598.
28. James ML, Fulton RR, Vercoullie J, et al. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization. J Nucl Med. 2008;49:814-822.